ADHD Statistics in New Mexico

Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental condition that affects both children and adults, impacting attention, impulse control, and executive function. Nationally, an estimated 15.5 million U.S. adults were living with a current ADHD diagnosis in 2023^[1], and approximately 11.4% of children have ever received a diagnosis^[7]. In New Mexico, ADHD is part of a broader mental health landscape where 22% of adults experienced some form of mental illness in the past year^[4], a rate slightly higher than the national average of 20.6%^[11]. Understanding the specific prevalence rates within the state is the first step toward addressing the unique challenges its residents face in accessing diagnosis and care.

ADHD does not affect all populations equally, with significant variations observed across age, gender, and socioeconomic lines. Nationally, boys are diagnosed with ADHD at significantly higher rates than girls^[7], with one study finding females are about 54% as likely as males to receive a diagnosis^[11]. Age is also a key factor; young adults aged 18–25 exhibit higher rates of mental health conditions (25%) compared to older adults (18%)^[14], and some datasets show ADHD prevalence may exceed 21% in the 18-24 age group^[13]. Furthermore, socioeconomic factors play a role, as children from households with lower income and education levels may be at an increased risk for an ADHD diagnosis^[11].

Despite the clear need, New Mexico residents face significant hurdles in accessing mental health care. The state ranks in the bottom quartile nationally for mental health support metrics^[4], a challenge compounded by a marked shortage of mental health professionals^[15]. Many counties in the state have been designated as Health Professional Shortage Areas (HPSAs) for mental health care^[15]. This problem is particularly acute in rural parts of New Mexico, where residents experience significantly lower access to specialists and are more likely to confront transportation and availability barriers when seeking care for ADHD^[13][8].

Economic barriers and long wait times further complicate access to care. Traditional, in-person ADHD assessments in New Mexico can be prohibitively expensive, often exceeding $1,000^[5], and wait times for an initial appointment can stretch up to nine months^[5]. In response, telehealth platforms are streamlining the process, with initial evaluations marketed for under $200^[5]. Importantly, New Mexico Medicaid (Turquoise Care) covers a range of telehealth services, including therapy and medication management, making this a viable option for many^[5]. Despite these advances, the state's overall investment in mental health services remains low, at around $120 per capita^[9].

Access to care has been further complicated by a national shortage of stimulant medications like Adderall. Recent media coverage has highlighted this as an emerging crisis in New Mexico, caused by a combination of supply chain disruptions and regulatory challenges^[16]. This shortage is not a minor inconvenience; a majority of adults receiving stimulant medication for ADHD have reported difficulties filling their prescriptions^[1]. The situation has forced many families in New Mexico to call multiple pharmacies or work with their doctors to switch medications, disrupting the continuity and effectiveness of their treatment^[2].

There is a common perception that ADHD is becoming more prevalent, but the data presents a more nuanced picture. While one longitudinal study noted a 20% increase in ADHD diagnoses among U.S. adolescents over the past decade^[2], many high-quality studies indicate that the true underlying prevalence of the disorder has remained relatively stable^[1][17]. The increase in diagnoses is likely due to greater public awareness, reduced stigma, and improved diagnostic practices. The COVID-19 pandemic also caused temporary shifts, with dips in prescription refills in 2020 followed by a rise in 2021, though these fluctuations appear to be transient^[18]. It's possible that pandemic-related stressors like remote schooling simply exacerbated existing attentional challenges, prompting more people to seek help^[7].

The significant gaps in treatment are concerning because untreated ADHD can have serious, long-term consequences. Children with unmanaged ADHD often experience academic underachievement, disrupted social relationships, and a higher risk for accidents or substance abuse later in life^[5]. These individual struggles contribute to broader public health challenges. In New Mexico, the high rate of untreated mental health conditions is reflected in severe outcomes, such as a suicide rate that is 50% higher than the U.S. average^[10]. Longitudinal data also shows a troubling trend, with annual suicide rates among young adults nationally increasing by approximately 5% between 2015 and 2020^[11].